The hybrid cells, readily detected in cancer patients’ blood, gain new powers to mobilize and form new tumors.
State-of-the-art cancer research facility will support a collaborative atmosphere, bring multidisciplinary scientists together under one roof.
Via a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.
Annual community event will offer free skin cancer exams, samples and services from skin care professionals, and a 5K Walk or Fun Run to benefit melanoma research.
OHSU’s 320,000 square foot cancer research building is taking shape, with completion slated for late summer 2018.
Apalutamide significantly delayed the onset of symptoms, metastasis or death in Phase III clinical trial.
Cancer researcher finds exercise DVD significantly improves fatigue symptoms in patients with breast cancer
Patients say exercise video is helpful at all stages of diagnosis and recovery.
September 28, 2017
Preparations are underway for the opening of the new CMH-OHSU Knight Cancer Collaborative in Astoria.
OHSU Knight Cancer Institute has been awarded the National Cancer Institute’s, NCI, premier status: Comprehensive Cancer Center.
Today the OHSU Knight Cancer Institute announced that internationally renowned bioengineering and technology expert Mike Heller, Ph.D., will join the institute’s Cancer Early Detection Advanced Research Center, or CEDAR, to lead its technology efforts.